ICNMD 2024

Registration

Registration for ICNMD 2024 is Open!

Join us in Perth, Australia for the 18th International Congress on Neuromuscular Diseases (ICNMD) 2024. Register by 19 June 2024 for early registration savings.

All fees below are in listed Australian dollars.

Early Registration

(until 19 June 2024)

Full Registration

$1,250

Student, Trainee or Resident Registration

$950

*Low or Middle Income Country (LMIC) Registration

$950

Day Registration (per day)

$550

Regular Registration

(until 30 August 2024)

Full Registration

$1,450

Student, Trainee or Resident Registration

$1,100

*Low or Middle Income Country (LMIC) Registration

$1,100

Day Registration (per day)

$650

Onsite Registration

(from 31 August 2024)

Full Registration

$1,600

Student, Trainee or Resident Registration

$1,250

*Low or Middle Income Country (LMIC) Registration

$1,250

Day Registration (per day)

$750

Early Registration
(until 19 June 2024)
Regular Registration
(until 30 August 2024)
Late/Onsite Registration
(from 31 August 2024)
Full Registration$1,250$1,450$1,600
Student, Trainee or Resident Registration$950$1,100$1,250
* Low or Middle Income Country (LMIC) Registration$950$1,100$1,250
Day Registration (per day)$550$650$750
Sponsor and Exhibitor Fees
Sponsor (based on allotment)Complimentary
Exhibitor Discounted Full Congress Registration$1,000
Exhibitor (based on allotment)Complimentary
Additional Exhibitor Staff$550
Ticketed Sessions

Ticketed sessions (hands on and teaching courses) can be registered for AUD$200 per session.  

Friday25 October, 2024
TimeTitleDescription
8:00am – 10:00amEmergencies in Neuromuscular DisordersFour topics (myasthenic crisis, rhabdomyolysis, respiratory failure and cardiac complications) will be presented by world renowned speakers. The emphasis will be on clinical practical issues: recognition of warning signs, established causes of such complications, diagnosis and management. The scientific basis of these conditions and their therapy will be also discussed. The course is relevant to young physicians and to practicing neuromuscular specialists.
8:00am – 10:00amEvaluation and Management of Clinical SyndromesThis teaching course will address the evaluation of clinical symptoms across the neuromuscular area. Swallowing difficulties occur frequently in motor neuron disease, neuromuscular junction disorders and myopathies and often go initially unnoticed, whereas they may cause a considerable disease burden. Distal muscle weakness of myopathic origin is rare but important to recognize and should be distinguished from neuropathies which usually manifest with distal muscle weakness, albeit sometimes a neuromyopathic cause can also be found. Pain and cramps are common complaints in the neuromuscular clinic. The differential diagnosis, evaluation and management of painful neuropathy and muscle cramps in neuromuscular disorders, respectively, will be discussed.
8:00am – 10:00amGenetic Issues in Neuromuscular Disorders (NMD)Recent advancements in genetics have revolutionized the diagnostic landscape for neuromuscular diseases. High-throughput sequencing techniques and refined bioinformatics tools have facilitated the rapid and precise identification of disease-causing genes and variants, enabling more accurate diagnosis. Moreover, genetic testing has become increasingly accessible and cost-effective, allowing for early detection and personalized management strategies. These developments offer hope for improved prognostication and targeted interventions, ushering in a new era of precision medicine in the realm of neuromuscular disorders. This session will provide an illustrated update of genetic diagnostic strategies and their limits in the field of myopathies, repeat expansion disorders, motor neuron diseases, and hereditary neuropathies.
8:00am – 10:00amUpdates of Nerve and Motor Neuron Disorders
PART 1
joint session: ICNMD & PNS
This course will provide an update on etiology, pathophysiology and treatment of peripheral neuropathies and related disorders. Specific topics include an update on GBS pathophysiology, TTR treatment options, CMT genetics and evolving therapies, as well as vasculitic neuropathy that can have different presentations. The session will feature expert reviews of the field, present recent and unpublished data, and will provide an outlook of things to come.
10:30am – 12:30pmCongenital HypotoniaHypotonia in early infancy may be a sign of a central nervous disorder (eg, hypoxic ischaemic encephalopathy), a primary neuromuscular disorder (eg congenital myopathy, congenital myasthenic syndrome), or a non-neuromuscular genetic syndrome associated with hypotonia (eg, Down syndrome, Prader-Willi syndrome). However, hypotonia also commonly occurs as a consequence of common neonatal conditions such as congenital infections, bacterial sepsis, hypothyroidism, hypoglycemia, and intracranial haemorrhage. This teaching session starts with information on how to delineate central from peripheral causes. It then goes on to give information on the three main groups of neuromuscular diseases that present as hypotonia and weakness in infancy, congenital myopathies, congenital myasthenic syndromes, and SMA and congenital muscular dystrophies. As treatments become available (eg. gene transfer for SMA), it becomes increasingly important that a correct diagnosis is arrived at as promptly as possible.
10:30am – 12:30pmMuscle HistopathologyThe aim of this teaching workshop is to describe muscle histopathology, pathobiology, and clinical features of different hereditary and acquired myopathies, and to familiarize the participants with the main diagnostic tool of muscle biopsy in the diagnosis of these disorders. The attendees will explore the nuances of hereditary myopathies including inclusion body myopathies, oculopharyngeal muscular dystrophy, oculopharyngodistal myopathy, GNE-myopathy, metabolic myopathies, and myofibrillar myopathies. Additionally the workshop will explore acquired inflammatory myopathies including inclusion body myositis, dermatomyositis, anti-synthetase syndrome, immune mediated necrotizing myopathy, and polymyositis, as well as myopathies that may be associated with inflammatory cell infiltration.

This workshop offers a valuable opportunity to clinicians, pathologists, and researchers to enhance their understanding of the muscle pathology in a variety of muscle disorders.
10:30am – 12:30pmDiagnostic Methods in NMDTBC
10:30am – 12:30pmUpdates of Nerve and Motor Neuron Disorders
PART 2
joint session: ICNMD & PNS
In this session, world leaders will discuss the mechanisms, diagnosis, and treatment of common neuromuscular conditions including ALS, myasthenia gravis, CIDP, and metabolic neuropathy. Specifically, Dr. Kiernan will focus on current understanding of the mechanisms leading to ALS. This will be followed by Dr. Reddel’s session, which will discuss the current and ever-changing treatments available for myasthenia gravis. The next lecture, by Dr. Koike, will examine the latest autoantibodies in CIDP including how these should be used in clinical practice. Finally, Dr. Callaghan will describe the evolving landscape of treatments for metabolic neuropathy.
1:30pm – 3:30pmCommon Neuromuscular Manifestations and Their DDTBC
1:30pm – 3:30pmMyasthenia Gravis: Pathophysiologic Basis for the Development of New TherapiesTherapeutic advances in generalized myasthenia gravis (MG) continue to grow rapidly, addressing both upstream aspects of auto-antibody production and their downstream effects. This course will review these advances. First, advances in the immunopathogenesis of MG will be discussed, with emphasis on how the understanding of pathophysiology influences the development of targeted therapies. Two major therapeutic targets, the complement cascade and neonatal Fc receptor blockade will then be discussed, with a review of recent clinical trial data for the agents in these categories. Immune mediated drug-induced MG and MG overlap syndromes are increasingly recognized as complications of Immune Checkpoint Inhibitors (ICIs). The last talk will address immune checkpoints, the mechanism of action of ICIs and the diagnosis and management of ICI induced MG.
Friday25 October, 2024
TimeTitleDescription
8:30am – 10:00amAdvance CareThis engaging and interactive session will provide participants with the opportunity to consider the role of advance care planning (ACP) in person-centred care. We will consider cultural issues in advance care planning, how to raise the issue with patients, and the process of completing the Western Australian statutory ACP document, the Advance Health Directive.
10:30am – 12:30pmNeurophysiologyEDX Evaluation of Neuromuscular Junction Disorders
This demonstration and hands-on workshop will include a discussion of the rationale and role of EDX in the evaluation of neuromuscular junction disorders in the EDX laboratory.  Participants will participate in a brief didactic session, will observe demonstrations of frequently used techniques, and will have the opportunity to practice these techniques with hands-on experience during the workshop.  Techniques for repetitive nerve stimulation, Single Fiber EMG (SFEMG), and routine needle examination will be demonstrated.
1:30pm – 3:30pmNeuromuscular Imaging UltrasoundThis workshop will review the use of ultrasound as a complementary technique in the EMG lab setting. Sessions will include a review of neuromuscular ultrasound and it’s role in the work up of peripheral nerve and muscle disease, followed by demonstrations covering ultrasound of the median and ulnar nerve, ultrasound of the diaphragm, ultrasound of muscle, and ultrasound guidance for needle EMG and chemodenervation. Content level will be directed at beginner to intermediate learners.
4pm – 5:30pmNeuromuscular Pathology Muscle and NerveIn this course, expert neuromuscular pathologists will present brief clinical vignettes from neuromuscular cases, foster discussion among the participants and will present the pathological findings from these cases. The pathology will focus on peripheral nerve and muscle biopsies. The biopsies will include photographs of tissues from both distal cutaneous nerve biopsies, from targeted fascicular nerve biopsies and from muscle biopsies. Three expert neuromuscular pathologists (two peripheral nerve and one muscle from Australia and the United States) will present the cases and lead the discussion.

Registration fees are inclusive of 10% Australian Goods and Services Tax (GST).
* Low or Middle Income Country (LMIC): please click here to check the list of low or middle-income countries.
* Proof of Student/Traineeship/Residency status is required at time of registration.

Full/Student/LMIC
Registration includes:

Single Day
Registration includes:

All visitors to Australia must have a valid visa to travel to and enter Australia. Once you have registered and paid the registration fees in full, a welcome letter will be emailed to you. It is strongly recommended that Australian visa applications are lodged at least 2-3 months prior to departure from your port of origin. Please visit https://immi.homeaffairs.gov.au/visas/getting-a-visa/visa-finder for more information.

Registration and attendance at, or participation in ICNMD 2024 constitutes an agreement by the registrant to the organiser’s use and distribution (both now and in the future) of the registrant or attendee’s image or voice in photographs, videotapes, electronic reproductions and audiotapes.

Please refer to https://arinex.com.au/privacy-policy/ for the full privacy policy.

Please note all online registrations require immediate payment by credit card.  Accepted credit cards are MasterCard, Visa and American Express. Please note all transactions by credit card will appear on your statement as payment to ‘Conference by Arinex’.

Payment must be received by the end of each registration deadline in order to receive the rate. Registration rates will automatically change to the next registration rate if not received in full.

Cancellations must be notified in writing to the Congress Managers at register.icnmd2024@arinexgroup.com.

Cancellations before Wednesday 19 June 2024 will incur an A$150.00 cancellation fee.

Cancellations from Thursday 20 June 2024 to Friday 27 September 2024 will incur a 50% cancellation fee.

Cancellations after Saturday 28 September 2024 will receive no refund.

Social Tickets: Payments are non-refundable as at Saturday 28 September 2024.

By allowing an exhibitor/sponsor to scan your badge, you will be consenting to your contact information being shared with that exhibitor/sponsor (name, job title, organisation, city, country and email address). Should you not wish to share your personal information with an exhibitor/sponsor, there is no obligation to allow your badge to be scanned by these parties.

Please note: Badge scanning for access by the Congress Organiser may be required and your information will remain confidential.

The Organiser of ICNMD 2024 (the “Event”) reserve the right to remove from the venue/Event at any time any attendee deemed to be causing, or potentially causing, a disturbance or exhibiting disruptive or inappropriate behaviour. Such removal does not constitute a right to refund of any fees paid. Please view the Code of Conduct here which all attendees are expected to comply with.